AMARIN CORP PLC\UK Derivative Liability, Fair Value, Gross Liability
AMARIN CORP PLC\UK (AMRN) had Derivative Liability, Fair Value, Gross Liability of $7.20 million as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2013-11-07
- 2013-09-30: Derivative Liability, Fair Value, Gross Liability $7.20M.
- 2013-06-30: Derivative Liability, Fair Value, Gross Liability $8.60M.
- 2013-03-31: Derivative Liability, Fair Value, Gross Liability $15.60M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2013-09-30 | $7.20M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $8.60M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $15.60M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |